Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 01 11 2019
accepted: 24 12 2019
pubmed: 26 12 2019
medline: 10 2 2021
entrez: 26 12 2019
Statut: ppublish

Résumé

Primary aldosteronism (PA) confers an increased risk of cardiovascular disease (CVD), independent of blood pressure. Animal models have shown that aldosterone accelerates atherosclerosis through proinflammatory changes in innate immune cells; human data are scarce. The objective of this article is to explore whether patients with PA have increased arterial wall inflammation, systemic inflammation, and reprogramming of monocytes. A cross-sectional cohort study compared vascular inflammation on 2'-deoxy-2'-(18F)fluoro-D-glucose; (18F-FDG) positron emission tomography-computed tomography, systemic inflammation, and monocyte phenotypes and transcriptome between PA patients and controls. This study took place at Radboudumc and Rijnstate Hospital, the Netherlands. Fifteen patients with PA and 15 age-, sex-, and blood pressure-matched controls with essential hypertension (EHT) participated. PA patients displayed a higher arterial 18F-FDG uptake in the descending and abdominal aorta (P < .01, P < .05) and carotid and iliac arteries (both P < .01). In addition, bone marrow uptake was higher in PA patients (P < .05). Although PA patients had a higher monocyte-to-lymphocyte ratio (P < .05), systemic inflammatory markers, cytokine production capacity, and transcriptome of circulating monocytes did not differ. Monocyte-derived macrophages from PA patients expressed more TNFA; monocyte-derived macrophages of healthy donors cultured in PA serum displayed increased interleukin-6 and tumor necrosis factor-α production. Because increased arterial wall inflammation is associated with accelerated atherogenesis and unstable plaques, this might importantly contribute to the increased CVD risk in PA patients. We did not observe inflammatory reprogramming of circulating monocytes. However, subtle inflammatory changes are present in the peripheral blood cell composition and monocyte transcriptome of PA patients, and in their monocyte-derived macrophages. Most likely, arterial inflammation in PA requires interaction between various cell types.

Identifiants

pubmed: 31875423
pii: 5686861
doi: 10.1210/clinem/dgz306
pmc: PMC7105350
pii:
doi:

Substances chimiques

Biomarkers 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Endocrine Society 2019.

Références

Biomed Res Int. 2018 Nov 11;2018:2703518
pubmed: 30534554
Circ Res. 2016 Feb 19;118(4):692-702
pubmed: 26892967
Physiol Res. 2016 Jun 20;65(2):229-37
pubmed: 26447510
Cell Metab. 2019 Jul 2;30(1):1-2
pubmed: 31204280
Cardiovasc Res. 2020 Feb 1;116(2):317-328
pubmed: 31119285
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Circ Res. 2006 Feb 3;98(2):186-91
pubmed: 16456111
Circ Res. 2016 Feb 19;118(4):620-36
pubmed: 26892962
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Medicine (Baltimore). 2018 Oct;97(43):e12813
pubmed: 30412071
Hypertens Res. 2012 Jan;35(1):123-5
pubmed: 21866108
JACC Cardiovasc Imaging. 2015 Feb;8(2):121-30
pubmed: 25577441
Nat Rev Immunol. 2017 Apr;17(4):233-247
pubmed: 28192415
J Stroke Cerebrovasc Dis. 2017 Nov;26(11):2595-2602
pubmed: 28847530
Atherosclerosis. 2011 Feb;214(2):249-56
pubmed: 20970139
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Hypertens. 2007 Jul;25(7):1451-7
pubmed: 17563568
J Clin Bioinforma. 2012 Mar 12;2:6
pubmed: 22409835
Eur Heart J. 2018 Oct 7;39(38):3521-3527
pubmed: 29069365
Clin Chem Lab Med. 2018 Feb 23;56(3):360-372
pubmed: 28844072
Bioinformatics. 2019 Jun 1;35(12):2084-2092
pubmed: 30395178
Int J Cardiol. 2012 Nov 15;161(2):103-10
pubmed: 22236514
J Intern Med. 2019 May;285(5):491-502
pubmed: 30585362
Lancet Diabetes Endocrinol. 2018 Jan;6(1):41-50
pubmed: 29129575
Eur Heart J. 2017 Feb 7;38(6):425-432
pubmed: 27357356
Curr Opin Nephrol Hypertens. 2017 Mar;26(2):97-104
pubmed: 27930384
JACC Cardiovasc Imaging. 2013 Dec;6(12):1250-9
pubmed: 24269261
J Am Coll Cardiol. 2018 Oct 30;72(18):2181-2197
pubmed: 30360827
Am J Hypertens. 2006 Sep;19(9):909-14
pubmed: 16942932
Biomed Res Int. 2016;2016:8609274
pubmed: 28101514
Cell. 2018 Jan 11;172(1-2):162-175.e14
pubmed: 29328911
Curr Atheroscler Rep. 2016 Jun;18(6):30
pubmed: 27108163
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Arthritis Res Ther. 2016 May 21;18(1):115
pubmed: 27209093
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Front Cardiovasc Med. 2018 Jul 09;5:81
pubmed: 30038907
Nat Commun. 2017 Aug 30;8(1):393
pubmed: 28855511
Thromb Haemost. 2016 Sep 27;116(4):626-37
pubmed: 27412877
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2763-8
pubmed: 17008591
Antioxid Redox Signal. 2018 Oct 10;29(11):1023-1040
pubmed: 28978221
Neth J Med. 1980;23(2):79-83
pubmed: 7374871
Atherosclerosis. 2016 Nov;254:228-236
pubmed: 27764724
Hemodial Int. 2018 Jan;22(1):82-92
pubmed: 28403540
Steroids. 2014 Dec;91:38-45
pubmed: 24769248
Science. 2013 Jan 11;339(6116):161-6
pubmed: 23307733
Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):780-92
pubmed: 26678270
Cardiovasc Res. 2018 Jun 1;114(7):944-953
pubmed: 29668907
Circ Res. 2012 May 11;110(10):1294-302
pubmed: 22474254
J Am Heart Assoc. 2013 Feb 22;2(1):e000018
pubmed: 23525413
Circ Res. 2018 Mar 2;122(5):664-669
pubmed: 29367213
Sci Rep. 2017 Aug 1;7(1):6989
pubmed: 28765576
Eur J Clin Invest. 2001 Jan;31(1):31-6
pubmed: 11168436

Auteurs

Charlotte D C C van der Heijden (CDCC)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Esther M M Smeets (EMM)

Department of Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

Erik H J G Aarntzen (EHJG)

Department of Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

Marlies P Noz (MP)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Houshang Monajemi (H)

Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands.

Simone Kersten (S)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.

Charlotte Kaffa (C)

Centre for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Alexander Hoischen (A)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.

Jaap Deinum (J)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Medicine, University Hospital Dresden, Technische Universität, Dresden, Germany.

Leo A B Joosten (LAB)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Medical Genetics, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Mihai G Netea (MG)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Department for Genomics & Immunoregulation, Life and Medical Sciences 12 Institute, University of Bonn, Bonn, Germany.

Niels P Riksen (NP)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH